HUTCHMED (China) (HCM) Raw Materials (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Raw Materials came in at $22.5 million in Q4 2025, down 7.79% year-on-year from $24.3 million in Q4 2024, and down 7.79% on a QoQ basis from $24.3 million in Q4 2024.
HUTCHMED (China) (HCM) Raw Materials (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Raw Materials data on file, last reported at $22.5 million in Q4 2025.
- On a quarterly basis, Raw Materials fell 7.79% year-over-year to $22.5 million in Q4 2025; TTM through Dec 2025 was $22.5 million, a 7.79% decrease from a year earlier, with the FY2025 full-year figure at $22.5 million, down 7.79% from the prior year.
- Raw Materials for Q4 2025 stood at $22.5 million, down from $24.3 million in the prior quarter.
- Over the last five years, Raw Materials for HCM reached as high as $27.4 million in Q4 2022 and fell as low as $15.8 million in Q4 2021.
- Historically, Raw Materials has averaged $23.4 million across 5 years, with a median of $24.3 million in 2024.
- Across the five-year window, Raw Materials soared 251.78% in 2021 and fell 9.09% in 2024, its largest moves.
- Year by year, Raw Materials stood at $15.8 million in 2021, then soared by 72.96% to $27.4 million in 2022, then dropped by 2.22% to $26.8 million in 2023, then fell by 9.09% to $24.3 million in 2024, then slipped by 7.79% to $22.5 million in 2025.
- Per Business Quant data, the three most recent Raw Materials figures were $22.5 million in Q4 2025, $24.3 million in Q4 2024, and $26.8 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.45 Mn |
| Dec 31, 2024 | 24.35 Mn |
| Dec 31, 2023 | 26.78 Mn |
| Dec 31, 2022 | 27.39 Mn |
| Dec 31, 2021 | 15.84 Mn |
| Dec 31, 2020 | 4.50 Mn |
| Dec 31, 2019 | 2.27 Mn |
| Dec 31, 2018 | 652,000.00 |
| Dec 31, 2017 | 314,000.00 |
| Dec 31, 2016 | 660,000.00 |
| Dec 31, 2015 | 753,000.00 |